Geode Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.57M | Buy |
3,107,096
+814,686
| +36% | +$3.46M | ﹤0.01% | 2402 |
|
|
2025
Q4 | $8.28M | Buy |
2,292,410
+275,025
| +14% | +$1.2M | ﹤0.01% | 2500 |
|
|
2025
Q3 | $7.61M | Buy |
2,017,385
+82,505
| +4% | +$319K | ﹤0.01% | 2572 |
|
|
2025
Q2 | $7.49M | Buy |
1,934,880
+228,995
| +13% | +$1.24M | ﹤0.01% | 2527 |
|
|
2025
Q1 | $8.53M | Buy |
1,705,885
+47,379
| +3% | +$300K | ﹤0.01% | 2390 |
|
|
2024
Q4 | $12M | Sell |
1,658,506
-9,498
| -0.6% | -$72.6K | ﹤0.01% | 2256 |
|
|
2024
Q3 | $10.2M | Buy |
1,668,004
+74,194
| +5% | +$503K | ﹤0.01% | 2363 |
|
|
2024
Q2 | $10.6M | Buy |
1,593,810
+357,012
| +29% | +$2.63M | ﹤0.01% | 2291 |
|
|
2024
Q1 | $12.6M | Buy |
1,236,798
+43,270
| +4% | +$440K | ﹤0.01% | 2188 |
|
|
2023
Q4 | $13.4M | Buy |
1,193,528
+140,192
| +13% | +$585K | ﹤0.01% | 2157 |
|
|
2023
Q3 | $2.74M | Buy |
1,053,336
+83,475
| +9% | +$239K | ﹤0.01% | 2954 |
|
|
2023
Q2 | $3.42M | Buy |
969,861
+487,500
| +101% | +$2.19M | ﹤0.01% | 2898 |
|
|
2023
Q1 | $2.04M | Buy |
482,361
+43,479
| +10% | +$517K | ﹤0.01% | 3023 |
|
|
2022
Q4 | $7.22M | Sell |
438,882
-37,185
| -8% | -$418K | ﹤0.01% | 2459 |
|
|
2022
Q3 | $6.08M | Buy |
476,067
+96,236
| +25% | +$1.42M | ﹤0.01% | 2563 |
|
|
2022
Q2 | $4.44M | Sell |
379,831
-261,990
| -41% | -$1.62M | ﹤0.01% | 2765 |
|
|
2022
Q1 | $3.91M | Buy |
641,821
+8,777
| +1% | +$64.6K | ﹤0.01% | 2935 |
|
|
2021
Q4 | $5.8M | Sell |
633,044
-25,808
| -4% | -$274K | ﹤0.01% | 2815 |
|
|
2021
Q3 | $7.45M | Buy |
658,852
+123,336
| +23% | +$1.5M | ﹤0.01% | 2676 |
|
|
2021
Q2 | $5.27M | Buy |
535,516
+286,386
| +115% | +$3.92M | ﹤0.01% | 2863 |
|
|
2021
Q1 | $3.52M | Buy |
249,130
+50,872
| +26% | +$822K | ﹤0.01% | 2953 |
|
|
2020
Q4 | $2.24M | Buy |
198,258
+18,687
| +10% | +$220K | ﹤0.01% | 3023 |
|
|
2020
Q3 | $2.37M | Buy |
179,571
+90,537
| +102% | +$1.81M | ﹤0.01% | 2786 |
|
|
2020
Q2 | $953K | Buy |
89,034
+2,859
| +3% | +$15.7K | ﹤0.01% | 3153 |
|
|
2020
Q1 | $276K | Hold |
86,175
| – | – | ﹤0.01% | 3452 |
|
|
2019
Q4 | $162K | Hold |
86,175
| – | – | ﹤0.01% | 3869 |
|
|
2019
Q3 | $168K | Buy |
86,175
+1,357
| +2% | +$3.01K | ﹤0.01% | 3835 |
|
|
2019
Q2 | $201K | Buy |
84,818
+35,644
| +72% | +$95.4K | ﹤0.01% | 3791 |
|
|
2019
Q1 | $142K | Buy |
49,174
+33,062
| +205% | +$98.5K | ﹤0.01% | 3822 |
|
|
2018
Q4 | $33K | Buy |
+16,112
| New | +$57K | ﹤0.01% | 4048 |
|
|
2018
Q3 | – | Sell |
-1,022
| Closed | -$13K | – | 4123 |
|
|
2018
Q2 | $13K | Sell |
1,022
-1,276
| -56% | -$25.1K | ﹤0.01% | 4050 |
|
|
2018
Q1 | $79K | Sell |
2,298
-1,020
| -31% | -$51.1K | ﹤0.01% | 3885 |
|
|
2017
Q4 | $198K | Sell |
3,318
-335
| -9% | -$21.4K | ﹤0.01% | 3680 |
|
|
2017
Q3 | $254K | Sell |
3,653
-61
| -2% | -$4.54K | ﹤0.01% | 3591 |
|
|
2017
Q2 | $356K | Sell |
3,714
-768
| -17% | -$128K | ﹤0.01% | 3488 |
|
|
2017
Q1 | $1.09M | Buy |
4,482
+2,842
| +173% | +$1.52M | ﹤0.01% | 2980 |
|
|
2016
Q4 | $1.6M | Buy |
1,640
+376
| +30% | +$337K | ﹤0.01% | 2756 |
|
|
2016
Q3 | $1.1M | Buy |
1,264
+13
| +1% | +$10.2K | ﹤0.01% | 2894 |
|
|
2016
Q2 | $915K | Buy |
1,251
+253
| +25% | +$173K | ﹤0.01% | 2942 |
|
|
2016
Q1 | $566 | Hold |
998
| – | – | ﹤0.01% | 3157 |
|
|
2015
Q4 | $569K | Hold |
998
| – | – | ﹤0.01% | 3211 |
|
|
2015
Q3 | $398K | Buy |
998
+270
| +37% | +$128K | ﹤0.01% | 3335 |
|
|
2015
Q2 | $392K | Hold |
728
| – | – | ﹤0.01% | 3309 |
|
|
2015
Q1 | $355K | Hold |
728
| – | – | ﹤0.01% | 3338 |
|
|
2014
Q4 | $395K | Hold |
728
| – | – | ﹤0.01% | 3288 |
|
|
2014
Q3 | $388K | Buy |
728
+147
| +25% | +$76.9K | ﹤0.01% | 3275 |
|
|
2014
Q2 | $245K | Hold |
581
| – | – | ﹤0.01% | 3446 |
|
|
2014
Q1 | $319K | Hold |
581
| – | – | ﹤0.01% | 3334 |
|
|
2013
Q4 | $324K | Hold |
581
| – | – | ﹤0.01% | 3253 |
|
|
2013
Q3 | $366K | Buy |
581
+108
| +23% | +$61.9K | ﹤0.01% | 3085 |
|
|
2013
Q2 | $225K | Buy |
+473
| New | +$235K | ﹤0.01% | 3190 |
|
Other funds holding ALT
VCM
VPM
N
Geode Capital Management's ALT Position: Q1 2026 in Review
Geode Capital Management increased its Altimmune (ALT) stake by 36% in Q1 2026, buying an estimated $3.46M and bringing the position to 3,107,096 shares worth $9.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2402.
Geode Capital Management first reported a position in ALT in Q2 2013 and has held it in 51 quarters since. The position peaked at $13.4M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.
- Geode Capital Management held 3,107,096 shares of Altimmune worth $9.57M as of Q1 2026.
- Geode Capital Management bought 814,686 Altimmune shares in Q1 2026, an estimated $3.46M.
- Altimmune made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2402 holding.
- Geode Capital Management first reported a position in Altimmune in Q2 2013 and has held it in 51 quarters since.
- Geode Capital Management's Altimmune position peaked at $13.4M in Q4 2023.
- 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.